75
Views
6
CrossRef citations to date
0
Altmetric
Review

Cost-effectiveness of smoking cessation and the implications for COPD

, &
Pages 279-287 | Published online: 20 Oct 2022

References

  • American Lung Association2005Chronic Obstructive Pulmonary Disease (COPD) fact sheet [online]Accessed 2 November 2005 URL: http://www.lungusa.org/site/apps/s/content.asp?c=dvLUK9O0E&b=34706&ct=67295
  • Anonymous1993Physician and other health care professional counseling of smokers to quit-United StatesMMWR Morb Mortal Wkly Rep4285478232167
  • BoydNFSutherlandHJHeasmanZ1990Whose utilities for decision analysis?Med Decis Making1058672182963
  • BrandonTHDeMicheleJT1995Expanding the target of relapse-prevention training to include self-quit ex-smokers: is there a need?Psychol Addict Behav911422
  • BrandonTHMeadeCDHerzogTA2004Efficacy and cost-effectiveness of a minimal intervention to prevent smoking relapse: dismantling the effects of amount of content versus contactJ Consult Clin Psychol7279780815482038
  • BuckDJRichmondRLMendelsohnCP2000Cost-effectiveness analysis of a family physician delivered smoking cessation programPrev Med31641811133329
  • BurnsMEBosworthTWFioreMC2004Insurance coverage of smoking cessation treatment for state employeesAm J Public Health9413384015284040
  • Centers for Disease Control and Prevention1999Cigarette smoking among adults-United StatesMMWR Morb Mortal Wkly Rep5086973
  • CinciripiniPMcClureJ1998Smoking cessation-recent developments in behavioral and pharmacologic interventionsOncology12249569507525
  • CurrySJGrothausLCMcAfeeT1998Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organizationN Engl J Med339673799725926
  • CurrySJMc BrideC1994Relapse prevention for smoking cessation: review and evaluation of concepts and interventionsAnnu Rev Public Health15345668054089
  • Department of Health and Human Services2005Coverage for tobacco use cessation treatments [online]Accessed 14 June 2006 URL: http://www.cdc.gov/Tobacco/educational_materials/cessation/ReimbursementBrochureFull.pdf
  • DollRPetoRWheatleyK1994Mortality in relation to smoking: 40 years’ observations on male British doctorsBMJ309901117755693
  • FeenstraTLHamberg-van ReenenHHHoogenveenRT2005Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling studyValue Health81789015877590
  • GarberAM1996Cost-effectiveness analysis as a measure of valueTechnologica39136910
  • GilbertARPingetCBovetP2004The cost effectiveness of pharmacological smoking cessation therapies in developing countries: a case study in the SeychellesTobacco Control13190515175539
  • GodfreyCFowlerG2002Pharmacoeconomic considerations in the management of smoking cessationDrugs62Suppl 2637012109937
  • GodfreyCParrottSColemanT2005The cost-effectiveness of the English smoking treatment services: evidence from practiceAddiction100Suppl 2708315844290
  • GrassoMEWellerWEShafferTJ1998Capitation, managed care, and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med5813389655719
  • HalpernMTKhanZMYoungTL2000Economic model of sustained-release bupropion hydrochloride in health plan and work site smoking-cessation programsAm J Health Syst Pharm571421910938982
  • HamC1995Priority setting in the NHSBritish Journal of Health Care Management1279
  • HaxbyDGBaldwinR1996The economics of smoking cessationAm J Health Syst Pharm537798719292
  • HaywardRAMeetzHKShapiroMF1989Utilization of dental services: 1986 patterns and trendsJ Public Health Dent49147522769632
  • HughesJRGulliverSFenwickJ1992Smoking cessation among self-quittersHealth Psychol1133141425551
  • JacksonGBobakAChorltonI2001Smoking cessation: a consensus statement with special reference to primary careInt J Clin Pract553859211501228
  • JavitzHSSwanGEZbikowskiSM2004aCost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspectiveAm J Manag Care102172615032259
  • JavitzHSSwanGEZbikowskiSM2004bReturn on investment of different combinations of bupropion SR dose and behavioral treatment for smoking cessation in a health care setting: an employer’s perspectiveValue Health75354315367249
  • JonkYCShermanSEFuSS2005National trends in the provision of smoking cessation aids within the veterans health administrationAm J Manag Care11778515726855
  • LennoxASOsmanLMReiterE2001Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomized controlled trialBMJ322139640111397745
  • MapelDWHurleyJSFrostFJ2000Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organizationArch Intern Med1602653810999980
  • McGhanWFSmithMD1995Pharmacoeconomic analysis of smoking cessation interventionsAm J Health Syst Pharm5345528719289
  • MininoAMSmithBL2001Deaths preliminary data for 2000National Center for Health Statistics, National Vital Statistics ReportsHyattville, MD, USA
  • MiravitllesMMurioCGuerreroT2003Costs of chronic bronchitis and COPD: a 1-year follow-up studyChest1237849112628879
  • MurrayCJLLopezAD1996Evidence-based health policy-Lessons from the Global Burden of Disease StudyScience27474038966556
  • National Heart, Lung, and Blood Institute2000Morbidity and mortality: chartbook on cardiovascular, lung, and blood diseasesBethesda, MDUS Department of Health and Human Services, Public Health Service, National Institutes of Health
  • NielsenKFioreMC2000Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessationPrev Med302091610684744
  • OckeneJKEmmonsKMMermelsteinRJ2000Relapse and maintenance issues for smoking cessationHealth Psychol19Suppl173110709945
  • PercivalJMilnerD2002Pharmacological management of smoking cessationBrit J Comm Nurs72025
  • PhillipsKAChenJL2002Impact of the U.S. Panel on cost-effectiveness in health and medicineAm J Prev Med229810511818178
  • RamseySDSullivanSD2003The burden of illness and economic evaluation for COPDEur Respir J21Suppl 41S2935
  • RonckersETGrootWAmentAJHA2005Systematic review of economic evaluations of smoking cessation: standardizing the cost-effectivenessMed Decis Making254374816061896
  • Secretary of State for Health and Secretaries of State for Scotland, Wales and Northern Ireland1998Smoking kills: a white paper on tobaccoLondonHMSO
  • SmithPOShefferCEPayneTJ2003Smoking cessation research in primary care treatment centers: the SCRIPT-MS projectAm J Med Sci3262384114557742
  • SongFRafteryJAveyardP2002Cost-effectiveness of pharmacological interventions for smoking cessation: a literature review and decision analytic analysisMed Decis Making22SupplS263712369228
  • StapletonJALowinARussellMAH1999Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectivenessLancet3542101510421303
  • StrasselsSA1999Economic consequences of chronic obstructive pulmonary diseaseCurr Opin Pulm Med5100410813259
  • SullivanSDRamseySDLeeTA2000The economic burden of COPDChest117S59
  • TengsTOWallaceA2000One thousand health-related quality-of-life estimatesMed Care3858363710843310
  • The Department of Health1990Blood cholesterol testingReport by the SMAC to the secretary of State for HealthLondonDepartment of Health
  • TomsonTHelgasonARGilljamH2004Quitline in smoking cessation: a cost-effectiveness analysisInt J Technol Assess Health Care204697415609797
  • TranMTHoldfordDAKennedyDT2002Modeling the cost-effectiveness of a smoking-cessation program in a community pharmacy practicePharamcotherapy22162331
  • UbelPARichardsonJMenzelP2000Societal value, the person tradeoff, and the dilemma of whose values to measure for cost-effectiveness analysisHealth Econ91273610721014
  • WardMMJavvitzHSSmithWM2000Direct medical cost of chronic obstructive pulmonary disease in the USARespir Med941123911127502
  • WarnerKEMendezDSmithDG2004The financial implications of coverage of smoking cessation treatment by managed care organizationsInquiry41576915224960
  • WarnerKESmithRJSmithDG1996Health and economic implications of a work-site smoking-cessation program: a simulation analysisJ Occup Environ Med38981928899574
  • WarnerKE1997Cost effectiveness of smoking-cessation therapies. Interpretation of the evidence and implications for coveragePharmacoeconomics115384910168094
  • WasleyMAMcNagnySEPhillipsVL1997The cost-effectiveness of the nicotine transdermal patch for smoking cessationPrev Med26264709085397
  • WestRMcNeillARawM2000Smoking cessation guidelines for health professionals: an updateThorax559879911083883
  • WestmaasJLVani NathBABrandonTH2000Contemporary smoking cessationCancer Control7566210740661
  • WilsonLDevineEBSoK2000Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysemaRespir Med942041310783930
  • ZaherCHalbertRDuboisR2004Smoking-related diseases: the importance of COPDInt J Tuberc Lung Dis81423815636487